Teladoc Health CEO Jason Gorevic unexpectedly departs, replaced by CFO Mala Murthy. The company faces challenges after Covid-19 growth, projecting single-digit growth. Teladoc’s stock has dropped from a high of $294 to $14 per share. The leadership change aims to navigate the company through this transition period. Wall Street analysts were surprised by the sudden announcement. Teladoc is seeking a new path forward amidst changing market conditions.
Source link
Teladoc CEO Jason Gorevic to leave the company immediately
